Montelukast Sodium Tablet, Chewable
Product Images NDC 63187-550

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 63187-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart (Montelukastcombine Figure 01)

Line graph comparing change in height (cm) over 56 weeks of treatment among three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis represents weeks on treatment, and the y-axis shows change in height. Montelukast and Placebo groups show similar trends, with Beclomethasone showing a slightly different pattern.*

FDA Label Image

Str (Montelukastcombine Figure 02)

Chemical structure diagram of Montelukast Sodium, showing its molecular framework including rings, functional groups, and the sodium carboxylate moiety.*

FDA Label Image

Chart2 (Montelukastcombine Figure 03)

A line graph showing the mean percent change from baseline over 15 weeks of treatment plus a 3-week washout period. Two groups are compared: Placebo (square markers) and Montelukast Sodium (circular markers). Montelukast Sodium shows a higher mean percent change from baseline compared to placebo throughout the treatment. Error bars are included for variability.*

FDA Label Image

Logo (Montelukastcombine Figure 04)

FDA Label Image

Table (Montelukastcombine Figure 05)

Text excerpt listing potential side effects related to Montelukast Sodium, including behavioral and psychological symptoms such as agitation, anxiety, hallucinations, irritability, memory problems, restlessness, suicidal thoughts, tremor, and trouble sleeping.*

FDA Label Image

Logo (Montelukastcombine Figure 06)

FDA Label Image

63187-550-30 (Montelukastcombine Figure 07)

Montelukast Sodium 4 mg chewable tablets label from Proficient Rx LP. The label indicates 30 tablets per package, each containing 4.2 mg montelukast sodium equivalent to 4 mg montelukast. Tablets are described as pink, oval biconvex, uncoated, with debossed markings '1079' and '4 MG'. Manufactured by Torrent Pharmaceuticals Ltd, India, with storage and safety instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.